Author: Hidayat, Rakhmad; Diafiri, Dinda; Zairinal, Ramdinal Aviesena; Arifin, Ghafur Rasyid; Azzahroh, Faiza; Widjaya, Nita; Fani, Devi Nurfadila; Mesiano, Taufik; Kurniawan, Mohammad; Al Rasyid,; Giantini, Astuti; Haris, Salim
Title: Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Cord-id: 20q09411 Document date: 2021_9_26
ID: 20q09411
Snippet: BACKGROUND Coronavirus disease-19 (COVID-19) is an infectious disease with high morbidity and mortality rates. Indonesia had reported a 2.8% of mortality rate up to June 2021. A strategy to control the virus spreading is by vaccination. The Indonesian Food and Drug Monitoring Agency had approved the use of CoronaVac, an inactivated virus vaccine developed by Sinovac. Most adverse events following immunization (AEFI) for CoronaVac are mild, and the most common symptoms are injection-site pain, he
Document: BACKGROUND Coronavirus disease-19 (COVID-19) is an infectious disease with high morbidity and mortality rates. Indonesia had reported a 2.8% of mortality rate up to June 2021. A strategy to control the virus spreading is by vaccination. The Indonesian Food and Drug Monitoring Agency had approved the use of CoronaVac, an inactivated virus vaccine developed by Sinovac. Most adverse events following immunization (AEFI) for CoronaVac are mild, and the most common symptoms are injection-site pain, headache, and fatigue. Neurovascular adverse events, including thrombosis or ischaemic stroke after receiving CoronaVac have not previously been reported. Correspondingly, we reported three patients with an Acute Ischaemic Stroke (AIS) after the administration of CoronaVac in our hospital.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date